The ACI today announces it will spearhead a CBD Safety Study Consortium to generate data to assess the safety of CBD. This move is in response to calls from regulators around the world who are highlighting the lack of evidence relating to the safety of CBD.
The ACI today welcomes five new hires to bolster our Regulatory and Compliance Unit. The unit, headed up by Dr Parveen Bhatarah, provides regulatory and compliance support to members of The ACI.
The ACI have received clarification from the FSA on several points concerning novel foods dossier applications that have been raised by our members.
The ACI announces high-level discussions with the Laboratory of Government Chemists (LGC) that will focus on the development of a cannabinoid testing methodology with a higher precision control, an essential step towards standardisation for the industry.
2pm BST, Wednesday 27 May 2020
With the new novel foods regulation deadline looming this event will provide a unique opportunity to listen and engage with representatives of the UK’s regulator the Foods Standards Agency as well as industry experts from trading standards, toxicology, and the analytical testing and legal worlds.
The Association for the Cannabinoid Industry today launched a free helpline for CBD companies wanting to continue operations in the UK after the FSA’s deadline of 31 March 2021.
The purpose of this timeline is to highlight the importance that CBD companies must start the process of Novel Foods applications now in order to avoid disruption in their distribution channels when FSA regulations come into force. We include the data required in a Novel Foods dossier followed by an estimate of time to produce this data.
The ACI is pleased to announce the publication of the peer-reviewed academic paper entitled “An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom”. Two… Read More »Academic Paper: An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom
The ACI congratulate Mile High Labs on the submission of their CBD Novel Foods dossier to the European Food Safety Authority (EFSA) and the UK Food Standards Agency (FSA).
The Food Standards Agency (FSA) confirmed last week, in a virtual meeting with the Association for the Cannabinoid Industry (The ACI), that they intend to stick to their deadline of 31 March 2021 for CBD companies to have a validated Novel Foods application.
